Lamberto Andreotti | |
---|---|
Born |
Rome, Italy | 6 July 1950
Alma mater |
Sapienza University of Rome (
BS) Massachusetts Institute of Technology ( MS) |
Occupation | Business executive |
Board member of |
|
Parents |
|
Lamberto Andreotti (born 6 July 1950) is an Italian businessman. He is currently executive chairman of the board of Bristol Myers Squibb. [1]
Andreotti was born in Rome, Italy, in 1950, the son of Italian Senator and President of the Council of Ministers Giulio Andreotti. He graduated from Sapienza University of Rome with a degree in engineering; he then earned a Master of Science degree from Massachusetts Institute of Technology. [2] [3] [4]
He worked for many pharmaceutical companies, including Farmitalia-Carlo Erba then with Pharmacia after Pharmacia acquired Farmitalia. [2]
In 1998, he joined Bristol-Myers Squibb as vice president and general manager of European Oncology and Italy. [2] He was elected to the Board of Directors in March 2009 and became CEO on 4 May 2010. [2] Prior to taking the role of CEO, he held the role of president and COO. [1] He retired from Bristol-Myers Squibb in 2015 and took on the role of executive chairman of the company's board, succeeding James M. Cornelius who was retiring from this role. [1]
He was elected to the board of DuPont in 2012. [5]
He was elected to the Board of Directors of UniCredit S.p.A. Bank on 12 May 2018.
Lamberto Andreotti | |
---|---|
Born |
Rome, Italy | 6 July 1950
Alma mater |
Sapienza University of Rome (
BS) Massachusetts Institute of Technology ( MS) |
Occupation | Business executive |
Board member of |
|
Parents |
|
Lamberto Andreotti (born 6 July 1950) is an Italian businessman. He is currently executive chairman of the board of Bristol Myers Squibb. [1]
Andreotti was born in Rome, Italy, in 1950, the son of Italian Senator and President of the Council of Ministers Giulio Andreotti. He graduated from Sapienza University of Rome with a degree in engineering; he then earned a Master of Science degree from Massachusetts Institute of Technology. [2] [3] [4]
He worked for many pharmaceutical companies, including Farmitalia-Carlo Erba then with Pharmacia after Pharmacia acquired Farmitalia. [2]
In 1998, he joined Bristol-Myers Squibb as vice president and general manager of European Oncology and Italy. [2] He was elected to the Board of Directors in March 2009 and became CEO on 4 May 2010. [2] Prior to taking the role of CEO, he held the role of president and COO. [1] He retired from Bristol-Myers Squibb in 2015 and took on the role of executive chairman of the company's board, succeeding James M. Cornelius who was retiring from this role. [1]
He was elected to the board of DuPont in 2012. [5]
He was elected to the Board of Directors of UniCredit S.p.A. Bank on 12 May 2018.